SEC Form 4 · accession 0000891293-15-000073
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Chief Scientific Officer · Director
Period of report
Dec 23, 2015
Accepted (ET)
Dec 23, 2015 · 7:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 23, 2015 | D | 236,858 | $0.00 | D | 1,069,992 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $1.24 | Dec 23, 2015 | A | 1,900,000 | A | — | Dec 23, 2025 | Common Stock | 1,900,000 | 1,900,000 | D |
Explanation of responses
- F1Represents the forfeiture back to CTIC of shares of restricted stock. The restricted shares were originally issued pursuant to a performance-based equity award effective as of January 3, 2012 and subsequently amended. The reporting person agreed to forfeit the restricted shares to the issuer. If a performance goal that had been applicable to such restricted stock is achieved by December 31, 2016, the reporting person will be entitled to the grant of a stock option from CTIC with respect to the same number of shares that would have been issued to the reporting person upon achievement of the goal under the original terms of the reporting person's long-term incentive award.
- F2The option is scheduled to vest in eight semi-annual installments over the four-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.